Visceral, inflammatory and neuropathic pain in glycine receptor alpha 3-deficient mice

NeuroReport

Volumn 16, Issue 18, 2005, Pages 2025-2028

  Rácz, Ildikó ^a   Schütz, Burkhard ^a   Abo Salem, Osama M ^a   Zimmer, Andreas ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Allodynia; Hyperalgesia; Inflammation; Knockout mouse; Neuropathic pain; Nociception

Indexed keywords

GLYCINE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INFLAMMATION; MOUSE; NEUROPATHIC PAIN; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RECEPTOR BINDING; THERMAL ANALYSIS; VISCERAL PAIN; WRITHING TEST;

ACETIC ACID; ANIMALS; FORMALDEHYDE; INFLAMMATION; IRRITANTS; MICE; MICE, MUTANT STRAINS; NEURALGIA; PAIN; PAIN MEASUREMENT; RECEPTORS, GLYCINE; SCIATIC NERVE; VISCERA;

EID: 28844444625     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200512190-00011     Document Type: Article

References (25)

1. Koltzenburg M. Painful neuropathies. Curr Opin Neurol 1998; 11:515-521.
2. Yaksh TL, Hua XY, Kalcheva I, Nozaki-Taguchi N, Marsala M. The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc Natl Acad Sci USA 1999; 96:7680-7686.
3. Svensson CI, Yaksh TL. The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol 2002; 42:553-583.
4. Vanegas H, Schaible HG. Prostaglandins and cyclooxygenases correction of cycloxygenases in the spinal cord. Prog Neurobiol 2001; 64:327-363.
5. Harvey RJ, Depner UB, Wassle H, Ahmadi S, Heindl C, Reinold H, et al. GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization. Science 2004; 304:884-887.
6. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33:87-107.
7. Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977; 4:161-174.
8. Konig M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ, et al. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 1996; 383:535-538.
9. Zimmer A, Zimmer AM, Baffi J, Usdin T, Reynolds K, Konig M, et al. Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proc Natl Acad Sci USA 1998; 95:2630-2635.
10. Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 1987; 30:103-114.
11. Malmberg AB, Yaksh TL. Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats. J Neurosci 1995; 15:2768-2776.
12. Hua XY, Calcutt NA, Malmberg AB. Neonatal capsaicin treatment abolishes formalin-induced spinal PGE2 release. Neuroreport 1997; 8:2325-2329.
13. Padi SS, Jain NK, Singh S, Kulkarni SK. Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor. Eur J Pharmacol 2004; 491:69-76.
14. Euchenhofer C, Maihofner C, Brune K, Tegeder I, Geisslinger G. Differential effect of selective cyclooxygenase-2 (COX-2) inhibitor NS 398 and diclofenac on formalin-induced nociception in the rat. Neurosci Lett 1998; 248:25-28.
15. Dirig DM, Konin GP, Isakson PC, Yaksh TL. Effect of spinal cyclooxygenase inhibitors in rat using the formalin test and in vitro prostaglandin E2 release. Eur J Pharmacol 1997; 331:155-160.
16. Tegeder I, Niederberger E, Vetter G, Brautigam L, Geisslinger G. Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord. J Neurochem 2001; 79:777-786.
17. Minami T, Nakano H, Kobayashi T, Sugimoto Y, Ushikubi F, Ichikawa A, et al. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice. Br J Pharmacol 2001; 133:438-444.
18. Parris WC, Janicki PK, Johnson B Jr, Horn JL. Intrathecal ketorolac tromethamine produces analgesia after chronic constriction injury of sciatic nerve in rat. Can J Anaesth 1996; 43:867-870.
19. Ma W, Du W, Eisenach JC. Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury. Brain Res 2002; 937:94-99.
20. De Vry J, Kuhl E, Franken-Kunkel P, Eckel G. Pharmacological characterization of the chronic constriction injury model of neuropathic pain. Eur J Pharmacol 2004; 491:137-148.
21. Zhu X, Eisenach JC. Cyclooxygenase-1 in the spinal cord is altered after peripheral nerve injury. Anesthesiology 2003; 99:1175-1179.
22. Miranda HF, Prieto JC, Pinardi G. Spinal synergy between nonselective cyclooxygenase inhibitors and morphine antinociception in mice. Brain Res 2005; 1049:165-170.
23. Berkenkopf JW, Weichman BM. Production of prostacyclin in mice following intraperitoneal injection of acetic acid, phenylbenzoquinone and zymosan: its role in the writhing response. Prostaglandins 1988; 36:693-709.
24. Matsumoto H, Naraba H, Ueno A, Fujiyoshi T, Murakami M, Kudo I, et al. Induction of cyclooxygenase-2 causes an enhancement of writhing response in mice. Eur J Pharmacol 1998; 352:47-52.
25. Ueno A, Matsumoto H, Naraba H, Ikeda Y, Ushikubi F, Matsuoka T, et al. Major roles of prostanoid receptors IP and EP(3) in endotoxin-induced enhancement of pain perception. Biochem Pharmacol 2001; 62:157-160.